1080 related articles for article (PubMed ID: 25956813)
21. Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901).
Peng W; Cao L; Chen L; Lin G; Zhu B; Hu X; Lin Y; Zhang S; Jiang M; Wang J; Li J; Li C; Shao L; Du H; Hou T; Chen Z; Xiang J; Pu X; Li J; Xu F; Loong H; Wu L
Oncologist; 2022 Mar; 27(2):e116-e125. PubMed ID: 35641209
[TBL] [Abstract][Full Text] [Related]
22. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization.
Walch AK; Zitzelsberger HF; Aubele MM; Mattis AE; Bauchinger M; Candidus S; Präuer HW; Werner M; Höfler H
Am J Pathol; 1998 Oct; 153(4):1089-98. PubMed ID: 9777940
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of Excellence.
Grøndahl V; Binderup T; Langer SW; Petersen RH; Nielsen K; Kjaer A; Federspiel B; Knigge U
Lung Cancer; 2019 Jun; 132():141-149. PubMed ID: 31097087
[TBL] [Abstract][Full Text] [Related]
24. [CGH findings in neuroendocrine tumours of the lung].
Johnen G; Krismann M; Jaworska M; Müller KM
Pathologe; 2003 Jul; 24(4):303-7. PubMed ID: 14513278
[TBL] [Abstract][Full Text] [Related]
25. Molecular Classification of Neuroendocrine Tumors of the Thymus.
Dinter H; Bohnenberger H; Beck J; Bornemann-Kolatzki K; Schütz E; Küffer S; Klein L; Franks TJ; Roden A; Emmert A; Hinterthaner M; Marino M; Brcic L; Popper H; Weis CA; Pelosi G; Marx A; Ströbel P
J Thorac Oncol; 2019 Aug; 14(8):1472-1483. PubMed ID: 31042566
[TBL] [Abstract][Full Text] [Related]
26. Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids.
Sturm N; Rossi G; Lantuejoul S; Papotti M; Frachon S; Claraz C; Brichon PY; Brambilla C; Brambilla E
Hum Pathol; 2002 Feb; 33(2):175-82. PubMed ID: 11957142
[TBL] [Abstract][Full Text] [Related]
27. Comparative proteomics of pulmonary tumors with neuroendocrine differentiation.
Cho NH; Koh ES; Lee DW; Kim H; Choi YP; Cho SH; Kim DS
J Proteome Res; 2006 Mar; 5(3):643-50. PubMed ID: 16512680
[TBL] [Abstract][Full Text] [Related]
28. Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases.
Jiang SX; Kameya T; Shoji M; Dobashi Y; Shinada J; Yoshimura H
Am J Surg Pathol; 1998 May; 22(5):526-37. PubMed ID: 9591721
[TBL] [Abstract][Full Text] [Related]
29. Neuroendocrine tumors of the lung: A five-year retrospective experience of Egyptian NCI (2010-2014).
Saber M; Ismail Y; Alieldin N; Loay I; El Zawahry M
J Egypt Natl Canc Inst; 2018 Dec; 30(4):151-158. PubMed ID: 30470605
[TBL] [Abstract][Full Text] [Related]
30. [Pulmonary neuroendocrine neoplasms].
Sayeg Y; Sayeg M; Baum RP; Kulkarni HR; Presselt N; Mäder I; Kunze A; Sänger J; Hörsch D; Bonnet R
Pneumologie; 2014 Jul; 68(7):456-77. PubMed ID: 25006841
[TBL] [Abstract][Full Text] [Related]
31. Molecular alterations of neuroendocrine tumours of the lung.
Rossi G; Bertero L; Marchiò C; Papotti M
Histopathology; 2018 Jan; 72(1):142-152. PubMed ID: 29239031
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical analysis of OTP and NKX6.1 in neuroendocrine tumors of the lung and pancreas.
Yoxtheimer LM; Heymann JJ; Cohen C; Rao RA; Goyal A; Siddiqui MT
Diagn Cytopathol; 2018 Dec; 46(12):1010-1014. PubMed ID: 30284410
[TBL] [Abstract][Full Text] [Related]
33. High grade neuroendocrine lung tumors: pathological characteristics, surgical management and prognostic implications.
Grand B; Cazes A; Mordant P; Foucault C; Dujon A; Guillevin EF; Barthes FLP; Riquet M
Lung Cancer; 2013 Sep; 81(3):404-409. PubMed ID: 23769675
[TBL] [Abstract][Full Text] [Related]
34. Bronchopulmonary neuroendocrine tumors.
Gustafsson BI; Kidd M; Chan A; Malfertheiner MV; Modlin IM
Cancer; 2008 Jul; 113(1):5-21. PubMed ID: 18473355
[TBL] [Abstract][Full Text] [Related]
35. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
Swarts DR; Ramaekers FC; Speel EJ
Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.
Brambilla E; Negoescu A; Gazzeri S; Lantuejoul S; Moro D; Brambilla C; Coll JL
Am J Pathol; 1996 Dec; 149(6):1941-52. PubMed ID: 8952529
[TBL] [Abstract][Full Text] [Related]
37. P16 is a useful supplemental diagnostic marker of pulmonary small cell carcinoma in small biopsies and cytology specimens.
Švajdler M; Mezencev R; Ondič O; Šašková B; Mukenšnábl P; Michal M
Ann Diagn Pathol; 2018 Apr; 33():23-29. PubMed ID: 29566943
[TBL] [Abstract][Full Text] [Related]
38. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
[TBL] [Abstract][Full Text] [Related]
39. The surgical spectrum of pulmonary neuroendocrine neoplasms.
Cooper WA; Thourani VH; Gal AA; Lee RB; Mansour KA; Miller JI
Chest; 2001 Jan; 119(1):14-8. PubMed ID: 11157578
[TBL] [Abstract][Full Text] [Related]
40. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Iijima H; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Pathol Res Pract; 2008; 204(8):553-61. PubMed ID: 18440724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]